【Covid 19】DNONCE (7114) DNONCE TECHNOLOGY BERHAD – GLOVES SUPPORT & VENTILATORS PARTS PRODUCER
Key Beneficiary related to Covid -19:
- Profitable Medical Devices producer
- Supporting industry for gloves particular in strong demand
- Recent change to reputable management FY2019
- Insider moves
Insider Moves: Toe Teow Heng, a Singaporean who surfaced in D’Nonce as a substantial shareholder in D’nonce Technology Berhad. Currently seating as Tianjin Phamarceutical (SG) International Investment Pte Ltd, Independent Director. TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company principally engaged in the manufacturing and sales of pharmaceuticals. The Company's principal businesses include the research, development and manufacture of Chinese patent medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine and nutraceuticals, as well as the distribution of pharmaceuticals. The Company's main products include cardiovascular and respiratory medicines, gastrointestinal drugs and anti-cancer drugs. Share price all time high at Singapore as well.
Why they want invest Dnonce Technology from Singapore to Malaysia? More contract move to Malaysia?
CEO said Covid 19 bring them more business than usual. Focus Malaysia already interview their management.
Supplier of packaging for Top Glovers Players, picture adopted from the website. Can you see the customer name in the label? Hahaha.
Join our Telegram Channel for our latest stock discussion.
All the information is available online and I compile for readers reference, this is not a buy call or sell call. Good day.